Back to Results
First PageMeta Content



Visterra to Present New Preclinical Results on VIS649, its Antibody for the Treatment of IgA Nephropathy, at the American Society of Nephrology Kidney Week Conference - VIS649 Reduced Serum IgA, with Favorable Safety Pro
Add to Reading List

Document Date: 2017-10-30 18:54:27


Open Document

File Size: 119,00 KB

Share Result on Facebook
UPDATE